Yuxiang Wang

2.0k total citations · 1 hit paper
83 papers, 1.4k citations indexed

About

Yuxiang Wang is a scholar working on Molecular Biology, Oncology and Epidemiology. According to data from OpenAlex, Yuxiang Wang has authored 83 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Molecular Biology, 22 papers in Oncology and 14 papers in Epidemiology. Recurrent topics in Yuxiang Wang's work include Adipokines, Inflammation, and Metabolic Diseases (6 papers), Lung Cancer Treatments and Mutations (6 papers) and Autophagy in Disease and Therapy (6 papers). Yuxiang Wang is often cited by papers focused on Adipokines, Inflammation, and Metabolic Diseases (6 papers), Lung Cancer Treatments and Mutations (6 papers) and Autophagy in Disease and Therapy (6 papers). Yuxiang Wang collaborates with scholars based in China, United States and United Kingdom. Yuxiang Wang's co-authors include Hui Li, Linghua Meng, L H Gong, Lynne Bingle, Weigang Fang, Yonghong Shi, Ning Wang, Liyin Zhu, Jeffrey W. Pollard and Hui Shi and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Nature Biotechnology.

In The Last Decade

Yuxiang Wang

80 papers receiving 1.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Metal nanoparticle hybrid hydrogels: the state-of-the-art of combining hard and soft materials to promote wound healing

2024 66 citations Yuxiang Wang, Mengya Zhang et al. Theranostics profile →

Peers

Countries citing papers authored by Yuxiang Wang

Since Specialization

Citations

This map shows the geographic impact of Yuxiang Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuxiang Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuxiang Wang more than expected).

Fields of papers citing papers by Yuxiang Wang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yuxiang Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuxiang Wang. The network helps show where Yuxiang Wang may publish in the future.

Co-authorship network of co-authors of Yuxiang Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Yuxiang Wang. A scholar is included among the top collaborators of Yuxiang Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yuxiang Wang. Yuxiang Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Quantitative Phase Imaging with a Meta-Based Interferometric System 2025 ·ACS Applied Materials & Interfaces ·Cheng Hung Chu, (unknown), Takeshi Yamaguchi, Yuxiang Wang, Takuo Tanaka, Huei‐Wen Chen, Yuan Luo, Din Ping Tsai	1
2	Predicting the risk of high-grade precancerous cervical lesions based on high-risk HPV typing in Changsha China 2025 ·BMC Women s Health ·(unknown), (unknown), Shaobo Wang, Yuxiang Wang, Weimin Miao, Meiwei Chen, Xiaowen Liu, Yan Chen, (unknown), Zhongping Deng, Lizhong Dai, (unknown), Jun He	1
3	Effect of Eu2O3 on sintering properties and resistance to slag wetting and penetration of MgO–MgAl2O4 refractory materials 2025 ·Journal of Iron and Steel Research International ·(unknown), Beiyue Ma, (unknown), (unknown), (unknown), Jialong Tian, Chao Yu, (unknown), Guangming Li, Chengcheng Zhang, Chengji Deng, Hongtao Shen, Yuxiang Wang, (unknown)	0
4	CDK14 regulates the development and repair of lung 2025 ·Cell Death Discovery ·Jianwei Chen, Yuxiang Wang, Rongrong Gao, (unknown), Jing Zhong, Jiaxin Yang, (unknown), Yuyan Li, (unknown), (unknown), Wenjing Guo, Ziyuan Zhou, Xiao Yu Tian, Jinjin Ma, Yang Liu, Qi Chen	1
5	Porous gradient hydrogel promotes skin regeneration by angiogenesis 2024 ·Journal of Colloid and Interface Science ·Jingyi Liu, (unknown), Huiling Chen, (unknown), Yuxiang Wang, Chen Zhou, Lei Tong, Peilei Wang, (unknown), Jie Liang, Yong Sun, Xingdong Zhang, Yujiang Fan	11
6	Oncogenic activation of PIK3CA in cancers: Emerging targeted therapies in precision oncology 2024 ·Genes & Diseases ·Yuxiang Wang, (unknown), Yiqing Zhao, Zhenghe Wang	6
7	Optimized anti-tuberculosis duration for drug-susceptible pulmonary tuberculosis-diabetes mellitus comorbidities: study protocol for a multicenter randomized controlled trial 2024 ·BMC Pulmonary Medicine ·Peize Zhang, (unknown), (unknown), (unknown), (unknown), (unknown), Yuxiang Wang, (unknown), (unknown), (unknown), Guang‐Hui Xu, Guofang Deng	0
8	Comparison of clinical and MRI features of brain metastases between ALK+ and ALK‐ NSCLC 2024 ·Cancer Medicine ·(unknown), Xuting Zhang, (unknown), (unknown), Ting Zhang, Yuxiang Wang, (unknown)	2
9	The Clinicopathological and Molecular Characteristics of Endocervical Gastric-Type Adenocarcinoma and the Use of Claudin18.2 as a Potential Therapeutic Target 2024 ·Modern Pathology ·Jing Yang, Peng Yang, Yan Ding, Yueping Liu, Yuxiang Wang, Yan Liu, (unknown)	10
10	Metal nanoparticle hybrid hydrogels: the state-of-the-art of combining hard and soft materials to promote wound healing breakdown → 2024 ·Theranostics ·Yuxiang Wang, Mengya Zhang, Zhenzhen Yan, Shizhao Ji, Shichu Xiao, Jie Gao	66
11	Role of TPEN in Amyloid-β25–35-Induced Neuronal Damage Correlating with Recovery of Intracellular Zn2+ and Intracellular Ca2+ Overloading 2023 ·Molecular Neurobiology ·Wenbo Chen, Yuxiang Wang, Hong‐Gang Wang, Di An, Dan Sun, Pan Li, Tao Zhang, Wange Lu, Yan‐qiang Liu	8
12	Human Umbilical Cord Mesenchymal Stromal Cell-Derived Exosomes Alleviate Hypoxia-Induced Pulmonary Arterial Hypertension in Mice Via Macrophages 2023 ·Stem Cells ·Hong Liu, Qingqing Zhang, Chuanchuan Liu, Yuwei Zhang, Yuxiang Wang, (unknown), Lan Ma, Ri‐Li Ge	9
13	Intact regulation of G1/S transition renders esophageal squamous cell carcinoma sensitive to PI3Kα inhibitors 2023 ·Signal Transduction and Targeted Therapy ·Xu Zhang, Yuxiang Wang, Xi Zhang, Yanyan Shen, Kang Yang, Qingyang Ma, (unknown), Jiajie Shi, Yi Wang, Lan Xu, (unknown), Gaoxiang Ge, Landian Hu, Xiangyin Kong, Chunhao Yang, Yi Chen, Jian Ding, Linghua Meng	6
14	Bak interacts with AKT and is involved in TNFα/CHX-induced apoptosis 2022 ·Molecular and Cellular Biochemistry ·(unknown), Fuqiang Zhang, Yu Wang, Yuxiang Wang, Jingtian Zhang, Zixuan Xiao, Xueqi Fu, Xuemin Xu, (unknown)	4
15	Covalent inhibitor targets KRasG12C: A new paradigm for drugging the undruggable and challenges ahead 2021 ·Genes & Diseases ·(unknown), (unknown), Yuxiang Wang, Linghua Meng	13
16	Genistein inhibits amyloid peptide 25-35-induced neuronal death by modulating estrogen receptors, choline acetyltransferase and glutamate receptors 2020 ·Archives of Biochemistry and Biophysics ·Yuxiang Wang, (unknown), (unknown), Lixia Li, Hong‐Gang Wang, Di An, Yan‐qiang Liu	13
17	Simultaneous inhibition of PI3Kα and CDK4/6 synergistically suppresses KRAS-mutated non-small cell lung cancer 2019 ·Cancer Biology and Medicine ·Yuxiang Wang, Xian Li, Xueling Liu, Yi Chen, (unknown), (unknown), Bobo Wang, Yiming Sun, Xi Zhang, (unknown), Jian Ding, Linghua Meng	23
18	Oleate promotes differentiation of chicken primary preadipocytes in vitro 2014 ·Bioscience Reports ·Zhouchun Shang, Lin Guo, Ning Wang, Hui Shi, Yuxiang Wang, Hui Li	53
19	Antiserums preparation and tissue expression analyses of chicken liver bile acid binding protein (L-BABP). 2011 ·Journal of Pharmaceutical and Biomedical Sciences ·(unknown), (unknown), Ning Ding, Yuxiang Wang, (unknown), Qigui Wang	3
20	In vitro study of HIF‐1 activation and VEGF release by bFGF in the T47D breast cancer cell line under normoxic conditions: involvement of PI‐3K/Akt and MEK1/ERK pathways 2005 ·The Journal of Pathology ·Yonghong Shi, Yuxiang Wang, Lynne Bingle, L H Gong, (unknown), Li Y, Weigang Fang	85

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact